Sort
48,018 grants matching “immunotherapy”
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$466,819Wenbin Lin · University Of Chicago · R01 · FY2023 · CA
Znf740 in the regulation of CD8+T cell exhaustion
$466,803Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2023 · CA
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$466,711Edgar G. Engleman · Stanford University · U54 · FY2019 · CA
Chemo-neoepitopes as novel immunotherapy for triple negative breast cancer
$466,702Pramod K. Srivastava · University Of Connecticut Sch Of Med/Dnt · R21 · FY2021 · CA
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$466,689Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2021 · NS
Peptide Vaccine To Prevent CMV Disease After HSCT
$466,660Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2007 · CA
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety
$466,659Dong Sung An · University Of California Los Angeles · U19 · FY2021 · AI
Neoadjuvant immunotherapy approaches to early stage melanoma
$466,650Meenhard Herlyn · Wistar Institute · P50 · FY2021 · CA
Costimulatory Signals in CD4+ T Cell Activation
$466,620Marc K. Jenkins · University Of Minnesota · R01 · FY2022 · AI
Costimulatory Signals in CD4+ T Cell Activation
$466,620Marc K. Jenkins · University Of Minnesota · R01 · FY2021 · AI
Costimulatory Signals in CD4+ T Cell Activation
$466,620Marc K. Jenkins · University Of Minnesota · R01 · FY2019 · AI
Costimulatory Signals in CD4+ T Cell Activation
$466,620Marc K. Jenkins · University Of Minnesota · R01 · FY2020 · AI
Immunoengineering Postdoctoral Training Program - Resubmission - 1
$466,604Melody A Swartz · University Of Chicago · T32 · FY2022 · AI
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$466,587Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$466,517Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$466,514Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Exploiting the microbiota-stromal cell axis for microbiota-targeted medicine
$466,500Meng Wu · Washington University · DP2 · FY2024 · AI
Regulation of Plasmodium-specific CD4+ T cells
$466,500Noah Sullivan Butler · University Of Iowa · R01 · FY2023 · AI
Development and function of CD4+ memory T cells during malaria
$466,500Noah Sullivan Butler · University Of Iowa · R01 · FY2023 · AI
Development and function of CD4+ memory T cells during malaria
$466,500Noah Sullivan Butler · University Of Iowa · R01 · FY2024 · AI
Regulation of Plasmodium-specific CD4+ T cells
$466,500Noah Sullivan Butler · University Of Iowa · R01 · FY2024 · AI
The Role of Lectins in Immune Recognition of Giardia
$466,500Steven M Singer · Georgetown University · R15 · FY2014 · AI
Antibody-based Therapy for Methamphetamine Abuse
$466,495University Of Arkansas Med Scis Ltl Rock · R01 · FY2004 · DA
Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection
$466,414Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2016 · AI